Clinical Trial Update: Extended Release Tacrolimus vs. Twice-Daily Tacrolimus [Phase 3]

View source ↗

Summary

Phase 3 trial comparing extended-release tacrolimus to twice-daily tacrolimus in renal transplant patients; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Renal Transplant Rejection

Drugs mentioned

• Extended-release tacrolimus (tacrolimus extended-release)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Lorenzo Gallon | Conditions: End Stage Renal Disease, Rejection of Renal Transplant | Phase 3 | Status: COMPLETED | Results posted: 2023-04-10